Related references
Note: Only part of the references are listed.Chemo-Resistant Protein Expression Pattern of Glioblastoma Cells (A172) to Perillyl Alcohol
Juliana de Saldanha da Gama Fischer et al.
JOURNAL OF PROTEOME RESEARCH (2011)
Molecular diagnostics of gliomas: state of the art
Markus J. Riemenschneider et al.
ACTA NEUROPATHOLOGICA (2010)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Peptide screening of cerebrospinal fluid in patients with glioblastoma multiforme
M. U. Schuhmann et al.
EJSO (2010)
Quantitative Proteomic Analysis of Oligodendrogliomas With and Without 1p/19q Deletion
Robert C. Rostomily et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Dynamic proteomic overview of glioblastoma cells (A172) exposed to perillyl alcohol
Juliana de Saldanha da Gama Fischer et al.
JOURNAL OF PROTEOMICS (2010)
Glioma proteomics: Status and perspectives
Simone P. Niclou et al.
JOURNAL OF PROTEOMICS (2010)
Super-SILAC mix for quantitative proteomics of human tumor tissue
Tamar Geiger et al.
NATURE METHODS (2010)
Decoding signalling networks by mass spectrometry-based proteomics
Chunaram Choudhary et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Differential proteome analysis of human gliomas stratified for loss of heterozygosity on chromosomal arms 1p and 19q
Michael Grzenclowski et al.
NEURO-ONCOLOGY (2010)
Establishing the Proteome of Normal Human Cerebrospinal Fluid
Steven E. Schutzer et al.
PLOS ONE (2010)
Clinical Applications of Metabolomics in Oncology: A Review
Jennifer L. Spratlin et al.
CLINICAL CANCER RESEARCH (2009)
Differential genomic and proteomic profiling of glioblastoma cells exposed to terpyridineplatinum(II) complexes
Sasa Koncarevic et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Proteomics strategies for target identification and biomarker discovery in cancer
Uros Rajcevic et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Multifarious proteomic signatures and regional heterogeneity in glioblastomas
Chul-Kee Park et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Proteomic Study of Human Glioblastoma Multiforme Tissue Employing Complementary Two-Dimensional Liquid Chromatography- and Mass Spectrometry-Based Approaches
Katja Melchior et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Identification of Gliotropic Factors That Induce Human Stem Cell Migration to Malignant Tumor
Jeung Hee An et al.
JOURNAL OF PROTEOME RESEARCH (2009)
iTRAQ-based Proteomics Profiling Reveals Increased Metabolic Activity and Cellular Cross-talk in Angiogenic Compared with Invasive Glioblastoma Phenotype
Uros Rajcevic et al.
MOLECULAR & CELLULAR PROTEOMICS (2009)
Proteome alteration of U251 human astrocytoma cell after inhibiting retinoic acid synthesis
Ming Zhang et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2009)
Multi-site assessment of the precision and reproducibility of multiple reaction monitoring-based measurements of proteins in plasma
Terri A. Addona et al.
NATURE BIOTECHNOLOGY (2009)
Applying mass spectrometry-based proteomics to genetics, genomics and network biology
Matthias Gstaiger et al.
NATURE REVIEWS GENETICS (2009)
Biomarker discovery in neurodegenerative diseases: A proteomic approach
Min Shi et al.
NEUROBIOLOGY OF DISEASE (2009)
Tissue Expression of Manganese Superoxide Dismutase Is a Candidate Prognostic Marker for Glioblastoma
Chul-Kee Park et al.
ONCOLOGY (2009)
Proteomics of tumor-specific proteins in cerebrospinal fluid of patients with astrocytoma: Usefulness of gelsolin protein
Mihoko Ohnishi et al.
PATHOLOGY INTERNATIONAL (2009)
Simultaneous extraction of nucleic acids and proteins from tissue specimens by ultracentrifugation: A protocol using the high-salt protein fraction for quantitative proteome analysis
Michael Grzendowski et al.
PROTEOMICS (2009)
Identification of secreted proteins regulated by cAMP in glioblastoma cells using glycopeptide capture and label-free quantification
Jennifer J. Hill et al.
PROTEOMICS (2009)
Up-regulation of NG2 proteoglycan and interferon-induced transmembrane proteins 1 and 3 in mouse astrocytoma: A membrane proteomics approach
Nicholas T. Seyfried et al.
CANCER LETTERS (2008)
SILAC mouse for quantitative proteomics uncovers kindlin-3 as an essential factor for red blood cell function
Marcus Krueger et al.
CELL (2008)
Serum α2-HS glycoprotein predicts survival in patients with glioblastoma
Vladimir Petrik et al.
CLINICAL CHEMISTRY (2008)
1st NCI Annual Meeting on Clinical Proteomic Technologies for Cancer
Feng Tao
Expert Review of Proteomics (2008)
Integrated analysis of the cerebrospinal fluid peptidome and proteome
Alexandre Zougman et al.
JOURNAL OF PROTEOME RESEARCH (2008)
Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers
Johan Skog et al.
NATURE CELL BIOLOGY (2008)
Identification of a novel proliferation-related protein, WHSC1 4a, in human gliomas
Jie Li et al.
NEURO-ONCOLOGY (2008)
Unique proteomic features induced by a potential antiglioma agent, Nordy (dl-nordihydroguaiaretic acid), in glioma cells
Xiu-Wu Bian et al.
PROTEOMICS (2008)
Investigation of molecular factors associated with malignant transformation of oligodendroglioma by proteomic study of a single case of rapid tumor progression
Chul-Kee Park et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2008)
The biological impact of mass-spectrometry-based proteomics
Benjamin F. Cravatt et al.
NATURE (2007)
Changes of metabolite profile in kainic acid induced hippocampal injury in rats measured by HRMAS NMR
Hui Mao et al.
EXPERIMENTAL BRAIN RESEARCH (2007)
Discovery of serum biomarkers in astrocytoma by SELDI-TOF MS and proteinchip technology
Haishi Zhang et al.
JOURNAL OF NEURO-ONCOLOGY (2007)
Identification of glioma neovascularization-related proteins by using MALDI-FTMS and Nano-LC fractionation to microdissected tumor vessels
Dana A. N. Mustafa et al.
MOLECULAR & CELLULAR PROTEOMICS (2007)
Proteome analysis of microdissected formalin-fixed and paraffin-embedded tissue specimens
Tong Guo et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2007)
Layered peptide array for multiplex immunohistochemistry
Gallya Gannot et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2007)
The 1p-encoded protein stathmin and resistance of malignant gliomas to nitrosoureas
Teri-T B. Ngo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2007)
Quick calculation for sample size while controlling false discovery rate with application to microarray analysis
Peng Liu et al.
BIOINFORMATICS (2007)
Detailed DNA methylation profiles of the E-cadherin promoter in the NCI-60 cancer cells
William C. Reinhold et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Proteomic investigation of glioblastoma cell lines treated with wild-type p53 and cytotoxic chemotherapy demonstrates an association between galectin-1 and p53 expression
Maja Puchades et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Biomarker discovery: A proteomic approach for brain cancer profiling
Ashraf A. Khalil et al.
CANCER SCIENCE (2007)
Proteomic identification of biomarkers in the cerebrospinal fluid (CSF) of astrocytoma patients
Fatima W. Khwaja et al.
JOURNAL OF PROTEOME RESEARCH (2007)
Electrophoretic separations of cerebrospinal fluid proteins in clinical investigations
Simona D'Aguanno et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2007)
A metabolomics perspective of human brain tumours
Julian L. Griffin et al.
FEBS JOURNAL (2007)
Proteomic identification of the wt-p53-regulated tumor cell secretome
F. W. Khwaja et al.
ONCOGENE (2006)
Functional and quantitative proteomics using SILAC
Matthias Mann
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Proteomic analysis of cerebrospinal fluid discriminates malignant and nonmalignant disease of the central nervous system and identifies specific protein markers
Fatima W. Khwaja et al.
PROTEOMICS (2006)
Direct-tissue SELDI-TOF mass spectrometry analysis: A new application for clinical proteomics
Ali Bonam-rani et al.
CLINICAL CHEMISTRY (2006)
Attractin is elevated in the cerebrospinal fluid of patients with malignant astrocytoma and mediates glioma cell migration
Fatima W. Khwaja et al.
CLINICAL CANCER RESEARCH (2006)
Protein disulfide isomerase expression is related to the invasive properties of malignant glioma
Dorota Goplen et al.
CANCER RESEARCH (2006)
Protein expression in experimental malignant glioma varies over time and is altered by radiotherapy treatment
C. Wibom et al.
BRITISH JOURNAL OF CANCER (2006)
Proteomics-based analysis of a pair of glioma cell lines with different tumor forming characteristics
Le Zhou et al.
NEUROSCIENCE LETTERS (2006)
Relative and absolute quantification of postsynaptic density proteome isolated from rat forebrain and cerebellum
Dongmei Cheng et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
Is current therapy of malignant gliomas beneficial for patients? Proteomics evidence of shifts in glioma cells expression patterns under clinically relevant treatment conditions
Daniela Trog et al.
PROTEOMICS (2006)
Pathway alterations during glioma progression revealed by reverse phase protein lysate arrays
Rongcai Jiang et al.
PROTEOMICS (2006)
Systematic immunohistochemical profiling of 378 brain tumors with 37 antibodies using tissue microarray technology
H Ikota et al.
ACTA NEUROPATHOLOGICA (2006)
Review - Mass spectrometry and protein analysis
B Domon et al.
SCIENCE (2006)
Proteomics-driven progress in neurodegeneration research
Michael Fountoulakis et al.
ELECTROPHORESIS (2006)
Proteomic profiling distinguishes astrocytomas and identifies differential tumor markers
J Li et al.
NEUROLOGY (2006)
State-of-the-art two-dimensional gel electrophoresis: a key tool of proteomics research
Odile Carrette et al.
NATURE PROTOCOLS (2006)
Proteome profile changes that are differentially regulated by lipid and protein phosphatase activities of tumor suppressor PTEN in PTEN-expressing U-87 MG human glioblastoma cells
JH Shim et al.
PROTEOMICS (2006)
Analysis of glioma cell platinum response by metacomparison of two-dimensional chromatographic proteome profiles
C Billecke et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
Proteome analysis of microdissected tumor tissue using a capillary isoelectric focusing-based multidimensional separation platform coupled with ESI-tandem MS
YJ Wang et al.
ANALYTICAL CHEMISTRY (2005)
Proteome analysis in the clinical chemistry laboratory: Myth or reality?
PG Righetti et al.
CLINICA CHIMICA ACTA (2005)
The development of the DIGE system: 2D fluorescence difference gel analysis technology
R Marouga et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2005)
Proteins and protein pattern differences between glioma cell lines and glioblastoma multiforme
TW Vogel et al.
CLINICAL CANCER RESEARCH (2005)
Proteomic studies on low- and high-grade human brain astrocytomas
F Odreman et al.
JOURNAL OF PROTEOME RESEARCH (2005)
Optimal replication and the importance of experimental design for gel-based quantitative proteomics
SMN Hunt et al.
JOURNAL OF PROTEOME RESEARCH (2005)
Differential protein expression in human gliomas and molecular insights
VC Chumbalkar et al.
PROTEOMICS (2005)
Human cerebrospinal fluid peptidomics
XL Yuan et al.
JOURNAL OF MASS SPECTROMETRY (2005)
Dynamics of CNS barriers: Evolution, differentiation, and modulation
NJ Abbott
CELLULAR AND MOLECULAR NEUROBIOLOGY (2005)
Imaging mass spectrometry: Principles and potentials
P Chaurand et al.
TOXICOLOGIC PATHOLOGY (2005)
Molecular classification and survival prediction in human gliomas based on proteome analysis
Y Iwadate et al.
CANCER RESEARCH (2004)
Protein profiling in brain tumors using mass spectrometry: Feasibility of a new technique for the analysis of protein expression
SA Schwartz et al.
CLINICAL CANCER RESEARCH (2004)
Protein patterns and proteins that identify subtypes of glioblastoma multiforme
M Furuta et al.
ONCOGENE (2004)
A model for random sampling and estimation of relative protein abundance in shotgun proteomics
HB Liu et al.
ANALYTICAL CHEMISTRY (2004)
Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents
PL Ross et al.
MOLECULAR & CELLULAR PROTEOMICS (2004)
Large-scate database searching using tandem mass spectra: Looking up the answer in the back of the book
RG Sadygov et al.
NATURE METHODS (2004)
Proteomics-based identification of differentially expressed genes in human gliomas: down-regulation of SIRT2 gene
M Hiratsuka et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Identification of tumor-related proteins by proteomic analysis of cerebrospinal fluid from patients with primary brain tumors
PP Zheng et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
Identification of differentially expressed proteins in human glioblastoma cell lines and tumors
RL Zhang et al.
GLIA (2003)
Mass spectrometry-based proteomics
R Aebersold et al.
NATURE (2003)
Evaluation of multidimensional chromatography coupled with tandem mass spectrometry (LC/LC-MS/MS) for large-scale protein analysis: The yeast proteome
JM Peng et al.
JOURNAL OF PROTEOME RESEARCH (2003)
Proteomics in primary brain tumors
PP Zheng et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2003)
Magnetic resonance image-guided proteomics of human glioblastoma multiforme
SK Hobbs et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2003)
Clinical proteomics: Translating benchside promise into bedside reality
EF Petricoin et al.
NATURE REVIEWS DRUG DISCOVERY (2002)
Amino acid residue specific stable isotope labeling for quantitative proteomics
HN Zhu et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2002)
Tissue microarray (TMA) technology:: miniaturized pathology archives for high-throughput in situ studies
L Bubendorf et al.
JOURNAL OF PATHOLOGY (2001)
Proteomic profiling from human samples: the body fluid alternative
S Kennedy
TOXICOLOGY LETTERS (2001)
Large-scale analysis of the yeast proteome by multidimensional protein identification technology
MP Washburn et al.
NATURE BIOTECHNOLOGY (2001)
Share Paper
